Emisphere Technologies, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Public, Subsidiary
- Established
- 1986-01-01
- Employees
- 51
- Market Cap
- -
- Website
- http://www.emisphere.com
Clinical Trials
2
Active:0
Completed:2
Trial Phases
1 Phases
Not Applicable:2
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Not Applicable
2 (100.0%)Efficacy and Safety Study of Oral Eligen® B12 in Subjects With Low Serum Cobalamin
Not Applicable
Completed
- Conditions
- Vitamin B 12 Deficiency
- First Posted Date
- 2011-03-11
- Last Posted Date
- 2011-03-11
- Lead Sponsor
- Emisphere Technologies, Inc.
- Target Recruit Count
- 49
- Registration Number
- NCT01312831
Oral Cyanocobalamin (Eligen B12) Bioavailability Study
- First Posted Date
- 2011-03-09
- Last Posted Date
- 2011-03-09
- Lead Sponsor
- Emisphere Technologies, Inc.
- Target Recruit Count
- 20
- Registration Number
- NCT01311739
News
No news found